GT Biopharma, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold GTBP, and how they changed the position last quarter. Latest holdings as of Jun 30, 2026. Source: SEC 13-F filings.
12
Funds holding
$95508
Total value held
Buying
9 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Northern Trust Corp | $36953 | 75461 | +75461 | NEW BUY |
| 2 | Pnc Financial Services Group, Inc. | $19600 | 40000 | +40000 | NEW BUY |
| 3 | Morgan Stanley | $11054 | 22573 | +5974 | +35.99% |
| 4 | Stonex Group Inc. | $8667 | 23258 | +8502 | +57.62% |
| 5 | Wells Fargo & Company/Mn | $7828 | 15986 | -51 | -0.32% |
| 6 | Blackrock, Inc. | $4070 | 8312 | -96 | -1.14% |
| 7 | Royal Bank Of Canada | $4000 | 7600 | +7474 | +5931.75% |
| 8 | Atlantic Union Bankshares Corp | $2620 | 5351 | +5351 | NEW BUY |
| 9 | Barclays Plc | $706 | 1441 | +1441 | NEW BUY |
| 10 | Amalgamated Financial Corp. | $9 | 2959 | +2959 | NEW BUY |
| 11 | Ubs Group Ag | $1 | 2 | +2 | NEW BUY |
| 12 | Jpmorgan Chase & Co | $0 | 1 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.